Lund University is recruiting a tenure-track Assistant Professor in Experimental Cancer Immunotherapy, and we want the best in the world to apply 🫵 The position comes with a clear path to tenure and an attractive start-up package. Apply or share with outstanding candidates by 10. June. 🔗 in replies
Kristian Pietras lab
@kpietraslab.bsky.social
We are studying tumor architecture to detail the constituent cell types controlling cancer initiation, spread and treatment response. Located @lund-university.bsky.social
Huge congratulations 🥳 to @jessicapantaleo.bsky.social for defending her doctoral thesis in such a graceful and expert manner! We are very proud of Dr Pantaleo, you deserve all the praise 👏 Big thanks to Faculty opponent @momobentires.bsky.social for insightful discussions and a generous attitude.
Starting 2026 in style 🕺💃! New paper out from talented PhD-student @jessicapantaleo.bsky.social who conceptualized the breast tumor microenvironment to visualize architectural structure in cancer-associated fibroblast niches. Thanks to all funders and collaborators😇 link.springer.com/article/10.1...
Spatial and temporal dynamics of cancer-associated fibroblast niches in breast cancer - Breast Cancer Research
Breast Cancer Research - Cancer-associated fibroblasts (CAFs) are the main constituents of the tumor microenvironment. Several studies have delineated CAF heterogeneity in different types of...
link.springer.com
Check this out👇 Our neighbors @pietraslab.bsky.social has just published a new preprint detailing high-resolution profiling of the irradiated GBM microenvironment. ❄️Cool reading for the holidays❄️ Thanks for including us!
📣 PREPRINT ALERT! Glioblastoma (GBM) often responds to radiotherapy, yet almost always recurs, frequently within high-dose radiation fields. www.biorxiv.org/content/10.6...
New paper alert 🚨 We are delighted to present our latest paper in @natcomms.nature.com through fabulous work from co-first authors Sebastian Braun and Paulina Bolivar! Big thanks to all expert collaborators for taking this long journey with us! Tweetorial in comments 🧵 www.nature.com/articles/s41...
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma - Nature Communications
Improved understanding of the tumor ecosystem in glioblastoma is critical for developing new treatment strategies for the disease. Here, the authors identify pericytes as an active paracrine signaling...
nature.com
Reflecting on the 2025 EACR Cancer Neuroscience Conference in Bilbao- what a friendly, inspiring meeting with many opportunities to increase connectivity, in that case to fight tumors. Big ‘Thank you’ to the organizers!
Don’t miss a joint LUCC-LBIC-ZEISS-ACD seminar on visualization of gene expression and biomarker localization in 2D, 3D and 4D. 16th June, BMC, Lund.
🚨 We’re hiring a bioinformatics-focused PhD student for our ERC-funded project on recurrent GBM! Focus: tumor-supportive microenvironment 🔬 Experience with scRNA-seq, spatial transcriptomics & Python/R a plus. Must be self-motivated & driven. DM for details! Repost=❤️ lu.varbi.com/en/what:job/...
Doctoral Student in Tumor Biology
Description of the workplace The research group conducts experimental research on brain tumors and is led by Associate Professor Alexander Pietras. The group consists of a bioinformatician, two postdo
lu.varbi.com
Swedish Childhood Cancer Fund (BCF) is raising awareness and support: today it is #Fotbollströjefredagen (Football shirt Friday)
Join us for innovative explorations of the tumor microenvironment🔬 Learn cutting-edge technologies and grow in a dynamic environment💡 The postdoc will work alongside a doctoral student from @adaptmet.bsky.social, gaining access to collaborative partners across 🇪🇺. Apply now👇 tinyurl.com/4mby45hf
Postdoc in Experimental Oncology - Lund (Stad), Skåne (SE) job with Lund University | 12838990
Lunds universitet, 009999 LUNDS UNIVERSITET, 310000 MED Lund University was founded in 1666 and is repeatedly ranked among the world’s top universi...
tinyurl.com
Targeting the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer! @kpietraslab.bsky.social & team @lund-university.bsky.social target the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer models! buff.ly/FXssb1x
We are proud to share that our PI has been named Cancer Researcher of the Year by @Cancerfonden! This well-deserved recognition highlights not only his outstanding contributions to cancer research but also his creativity in tackling scientific challenges and his inspiring leadership within our team.
Kristian Pietras – Årets cancerforskare 2025
Kristian Pietras forskar om hur celler i blodkärl och bindväv påverkar cancerns möjlighet att växa eller dö. Nu tilldelas han utmärkelsen Årets cancerforskare.
cancerfonden.se
🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch
At the Brain Tumor Microenvironment Symposium @institutducerveau.bsky.social, Sebastian Braun presented our comprehensive study of pericytes in GBM 🤩. Pericytes act as guardians of the peri-vascular niche to prevent malignant cell invasion, read more at www.biorxiv.org/content/10.1...
@jessicapantaleo.bsky.social making us proud at the @lund-university.bsky.social Cancer Centre Tumor Microenvironment retreat by presenting our latest findings on CAF subtype spatial organization across longitudinally sampled experimental breast cancers.
Thanks @oncogenejournal for highlighting our work on cancer-associated fibroblasts that enable endocrine resistance in luminal breast cancer www.nature.com/collections/...
Readers Choice: The best of Oncogene 2024
In this collection we highlight a selection of articles from 2024, which top the list of the journal’s most cited, downloaded and most shared (including press ...
nature.com
Last chance to apply, call closes on Jan 17th!
We are live 🕺! Recruitment for the exciting MSCA doctoral network Adaptmet is now open. Join us and great collaborators across Europe to explore fundamental mechanisms of metastatic dissemination: adaptmet.eu/recruitment/
We have been waiting impatiently but can finally share our latest efforts in understanding the biology of the TGF-beta type I receptor ALK1 (gene name ACVRL1), see graphical abstract in post and the full article here: www.jci.org/articles/vie... 1/6
The two Pietras labs @pietraslab.bsky.social @kpietraslab.bsky.social collide in a fierce game of Ping Pong. The losers fill all pipette tip boxes the next year 😜
Kristian Pietras @kpietraslab.bsky.social at Lund University @lunduniversity.bsky.social will oversee DC4 who will work on the suppression of metastatic dissemination through precision targeting of cancer-associated fibroblast niches
We love to explore unexpected findings 🤔 Check out our two latest studies detailing the unexplored expression of ALK1 in immunosuppressive macrophages and the critical role of pericytes as a paracrine signaling hub in GBM. www.biorxiv.org/content/10.1... www.biorxiv.org/content/10.1...
We are live 🕺! Recruitment for the exciting MSCA doctoral network Adaptmet is now open. Join us and great collaborators across Europe to explore fundamental mechanisms of metastatic dissemination: adaptmet.eu/recruitment/
Recruitment
Recruitment is now open! Apply for one of the 16 positions availablein the Adaptmet network and build your futureas a researcher in metastasis! Adaptmet is offering generous three-year fellowship...
adaptmet.eu
Hi Bluesky 👋 Looking forward to exciting interactions with the cancer research community. We are students of tumor architecture, aiming to establish the organizational principles of the tumor microenvironment.